We’ve got a packed DDN for you – because there’s so much to say before we take a break for four weeks in August.
The crucial issues won’t wait. The diamorphine crisis, spelled out in our 27 June issue, is getting worse by the minute for those caught up in it, and it’s affecting more than just a handful of patients.
The medical profession, user groups and the DAT joined forces months ago in Cornwall, to campaign for swift resolution, and the stalemate is astonishing (page 9). Can anyone shed light on why it’s taking so long to get supplies resumed?
This edition’s bursting at the staples with pressing policy issues – not least why the government’s findings on drug policy effectiveness have been shuffled past us. Steve Rolles from the Transform Drug Policy Foundation raises a challenge for clarity – and where necessary – revision.